{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:14:24Z","timestamp":1791422064236,"version":"4.3.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1409,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["04-2010-101"],"award-info":[{"award-number":["04-2010-101"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["20100020584"],"award-info":[{"award-number":["20100020584"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["0720440"],"award-info":[{"award-number":["0720440"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004084","name":"Korea Science and Engineering Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.bbmt.2011.01.002","type":"journal-article","created":{"date-parts":[[2011,1,9]],"date-time":"2011-01-09T04:22:37Z","timestamp":1294546957000},"page":"810-820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Increased Copy Number of the Interleukin-6 Receptor Gene Is Associated with Adverse Survival in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation"],"prefix":"10.1016","volume":"17","author":[{"given":"Seon Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jung","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Kyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cha Ja","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Mee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonyang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Kook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Soon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2011.01.002_bib1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2011.01.002_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc746","article-title":"Multiple myeloma: evolving genetic events and host interactions","volume":"2","author":"Kuehl","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bbmt.2011.01.002_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/leu.2008.291","article-title":"Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma","volume":"23","author":"Kyle","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2011.01.002_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","article-title":"Multiple myeloma","volume":"374","author":"Raab","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2011.01.002_bib5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.leu.2402924","article-title":"Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms","volume":"17","author":"Nefedova","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2011.01.002_bib6","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","article-title":"The role of IL-6 and STAT3 in inflammation and cancer","volume":"41","author":"Hodge","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bbmt.2011.01.002_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1189\/jlb.1105674","article-title":"Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer","volume":"80","author":"Rose-John","year":"2006","journal-title":"J Leuk Biol"},{"key":"10.1016\/j.bbmt.2011.01.002_bib8","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1860::AID-CNCR7>3.0.CO;2-R","article-title":"The prognostic value of soluble interleukin-6 receptor in patients with multiple myeloma","volume":"82","author":"Stasi","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2011.01.002_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1365-2141.1996.d01-1470.x","article-title":"Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Finnish Leukaemia Group","volume":"92","author":"Pulkki","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2011.01.002_bib10","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/blood.V77.12.2794.2794","article-title":"Interleukin-6 is a prognostic factor in multiple myeloma","volume":"77","author":"Ludwig","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.01.002_bib11","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1158\/0008-5472.CAN-06-3641","article-title":"Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor","volume":"67","author":"Yoshio-Hoshino","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2011.01.002_bib12","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging\u00a0system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.01.002_bib13","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2011.01.002_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-4608(97)00058-7","article-title":"A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies","volume":"101","author":"Ahmann","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.bbmt.2011.01.002_bib15","unstructured":"Slovak ML, LJ C, eds. International System of Human Cytogenetic Nomenclature. Basel: Karger AG, 2009."},{"key":"10.1016\/j.bbmt.2011.01.002_bib16","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.leu.2402116","article-title":"Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization","volume":"15","author":"Gutierrez","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2011.01.002_bib17","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V91.8.3007.3007_3007_3010","article-title":"Characterization of\u00a0nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization","volume":"91","author":"Cigudosa","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.01.002_bib18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/(SICI)1098-2264(199706)19:2<124::AID-GCC8>3.0.CO;2-0","article-title":"Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization","volume":"19","author":"Avet-Loiseau","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bbmt.2011.01.002_bib19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bbmt.2009.11.025","article-title":"Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy","volume":"16","author":"Nemec","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.01.002_bib20","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1182\/blood-2006-03-009910","article-title":"Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation","volume":"108","author":"Hanamura","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.01.002_bib21","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1038\/sj.leu.2404403","article-title":"Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma","volume":"20","author":"Fonseca","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2011.01.002_bib22","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1182\/blood-2006-07-038703","article-title":"CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms","volume":"109","author":"Zhan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.01.002_bib23","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","article-title":"A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1","volume":"109","author":"Shaughnessy","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.01.002_bib24","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2006-08-040410","article-title":"Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome","volume":"109","author":"Avet-Loiseau","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.01.002_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbmt.2005.10.002","article-title":"Using genomics to identify high-risk myeloma after autologous stem cell transplantation","volume":"12","author":"Shaughnessy","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.01.002_bib26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2141.2006.06237.x","article-title":"Significant increase of CKS1B amplification from monoclonal gammopathy of undetermined significance to multiple myeloma and plasma cell leukaemia as demonstrated by interphase fluorescence in situ hybridisation","volume":"134","author":"Chang","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2011.01.002_bib27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2141.2006.06325.x","article-title":"Multiple myeloma patients with CKS1B gene amplification have a shorter progression-free survival post-autologous stem cell transplantation","volume":"135","author":"Chang","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2011.01.002_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/leu.2008.259","article-title":"Bone marrow microenvironment and the identification of new targets for myeloma therapy","volume":"23","author":"Podar","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2011.01.002_bib29","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1182\/blood-2006-04-015149","article-title":"Targeting mitochondrial factor Smac\/DIABLO as therapy for multiple myeloma (MM)","volume":"109","author":"Chauhan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.01.002_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/0008-5472.CAN-08-0613","article-title":"Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells","volume":"69","author":"Ara","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2011.01.002_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3324\/haematol.11080","article-title":"Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders","volume":"93","author":"Rawstron","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2011.01.002_bib32","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1182\/blood.V96.12.3880","article-title":"The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells","volume":"96","author":"Rawstron","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.01.002_bib33","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0301-472X(01)00682-8","article-title":"Expression of IL-6 and IL-6 receptors by circulating clonotypic B cells in multiple myeloma: potential for autocrine and paracrine networks","volume":"29","author":"Szczepek","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2011.01.002_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ijc.23941","article-title":"Soluble and membrane levels of molecules involved in the interaction between clonal plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease","volume":"124","author":"Perez-Andres","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bbmt.2011.01.002_bib35","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.leukres.2006.08.002","article-title":"Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed\/refractory multiple myeloma","volume":"31","author":"Chang","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2011.01.002_bib36","first-page":"3854","article-title":"Multiple myeloma: high\u00a0incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization","volume":"55","author":"Drach","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2011.01.002_bib37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1470-2045(04)01511-6","article-title":"New drugs for treatment of multiple myeloma","volume":"5","author":"Bruno","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2011.01.002_bib38","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1158\/1078-0432.CCR-04-2611","article-title":"Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu in vivo model\u00a0of human multiple myeloma","volume":"11","author":"Tassone","year":"2005","journal-title":"Clin Cancer Res"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911100005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911100005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:39:33Z","timestamp":1761057573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387911100005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S108387911100005X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.01.002","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Copy Number of the Interleukin-6 Receptor Gene Is Associated with Adverse Survival in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}